This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Cytune Pharma, Institut Gustave Roussy. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 8 
1 out of 101 
Years Active: 2022
Title: Nathalie Chaput: Innovator in Cancer Treatment
Introduction
Nathalie Chaput is a prominent inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. Her innovative work focuses on enhancing the efficacy of immune responses against cancer and infections.
Latest Patents
Nathalie holds a patent for a groundbreaking invention titled "Cytokine derived treatment with reduced vascular leak syndrome." This patent describes a pharmaceutical composition that utilizes an interleukin 15 (IL-15) derivative conjugate. The aim is to induce a proliferation of natural killer cells (NK cells) that matches or exceeds the proliferation achieved with high doses of interleukin-2 (HDIL-2). This treatment is potentially associated with a pharmaceutically acceptable carrier, offering a promising approach to cancer therapy.
Career Highlights
Throughout her career, Nathalie has worked with esteemed organizations such as Institut Gustave Roussy and Cytune Pharma. Her experience in these institutions has allowed her to develop and refine her innovative ideas in the pharmaceutical sector.
Collaborations
Nathalie has collaborated with notable professionals in her field, including David Bechard and Melanie Desbois. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Nathalie Chaput is a trailblazer in the realm of cancer treatment, with her patent reflecting her commitment to improving patient outcomes. Her work continues to inspire advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile